REFERENCES
- Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 1995; 24: 481–509, [PUBMED], [INFOTRIEVE]
- De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316–322, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92: 1558–1564, [PUBMED], [INFOTRIEVE]
- Kazanagra R, Cheng V, Garcia A, et al. A rapid test for B‐natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001; 37: 386–391, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med 1998; 30(suppl)39–45, [PUBMED], [INFOTRIEVE]
- Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22–30, [PUBMED], [INFOTRIEVE]
- Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL. PRAISE-2 study investigators. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischemic origin. Eur J Heart Fail 2005; 7(4)557–565, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hulsmann M, Berger R, Mortl D, Gore O, Meyer B, Pacher R. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail 2005; 7(4)552–556, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ishizaka Y, Yamamoto Y, Fukunaga T, et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461–472, [PUBMED], [INFOTRIEVE]
- Nitta K, Kawashima A, Yumura W, et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 1998; 8: 411–415, [CROSSREF]
- Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59: 1559–1566, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic cardiovascular disease in end-stage renal disease: prevalence, associations and prognosis. Kidney Int 1995; 47: 186–192, [PUBMED], [INFOTRIEVE]
- Levey S. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?. Am J Kidney Dis 1998; 32(5 suppl 3)S5–S13, [PUBMED], [INFOTRIEVE]
- Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277–1285, [PUBMED], [INFOTRIEVE]
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(5 suppl 3)S112–S119, [PUBMED], [INFOTRIEVE]
- Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. Am Soc Nephrol 2001; 12: 1508–1515
- Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med 2002; 10(4)457–461, [PUBMED], [INFOTRIEVE]
- Hoeben H, Van Biesen W, Lameire N. Cardiovascular problems in peritoneal dialysis patients: a short review. Perit Dial Int 1998; 19: 150–158
- Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083, [PUBMED], [INFOTRIEVE]
- Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613–618, [PUBMED], [INFOTRIEVE]
- McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnosis breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72–80, [PUBMED], [INFOTRIEVE]
- Chen HH, Burnett JC, Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 1999; 111: 406–416, [PUBMED], [INFOTRIEVE]
- Tonolo G, McMillan M, Polonia J, et al. Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. Am J Physiol 1988; 254: 895–899
- Smith MW, Espiner EA, Yandle TG, Charles CJ, Richards AM. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol 2000; 167: 239–246, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kohse KP, Feifel K, Mayer-Wehrstein R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993; 40: 83–90, [PUBMED], [INFOTRIEVE]
- Iwashima Y, Horio T, Takami Y, et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002; 40: 974–982, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fagugli RM, Palumbo B, Ricciardi D, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95(2)c60–c66, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goto T, Takase H, Toriyama T, et al. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 2002; 92: 610–615, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ishii J, Ishikawa T, Yukitake J, et al. Clinical specificity of a second-generation cardiac troponin T assay in patients with chronic renal failure. Clin Chim Acta 1998; 270: 183–188, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and predict mortality in dialysis patients. Am Soc Nephrol 2001; 12: 1508–1515